| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 77,300 | 31 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123022751-clem-kerry-m-2023-03-31 | Acorda Therapeutics, Inc. | 31 Mar 2023 | 1 | $0 | 4 | Chief Commercial Officer | 04 Apr 2023, 16:40 |
| /report/000120919122048947-clem-kerry-m-2022-09-03 | ACORDA THERAPEUTICS INC | 03 Sep 2022 | 1 | -$601 | 4 | Chief Commercial Officer | 07 Sep 2022, 07:59 |
| /report/000120919121056971-clem-kerry-m-2021-09-09-restatement | ACORDA THERAPEUTICS INC | 09 Sep 2021 | 0 | $0 | 3/A | Chief Commercial Officer | 20 Sep 2021, 20:20 |